Unlike tirzepatide, it is a triple agonist , acting on GLP-1, GIP, and glucagon receptors
The primary endpoints was the percent change from baseline in body weight, while secondary endpoints included change from baseline in body mass index (BMI), waist circumference and systolic blood pressure
This leads me to the first pitfall
Endocrinology (1996) 137(7):296878.10.1210/endo.137.7.8770921 50 YustaBBaggioLLKoehlerJHollandDCaoXPinnellLJet alGLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R
When administering the lower dose of Semaglutide at 1 mg to treat patients with diabetes, the SUSTAIN study consistently demonstrated significant improvements in glucose control and body weight reduction 29,30,31,32,33,34,35